|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4657 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3357 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3357 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 5457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 3057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4357 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 4857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 2710 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 3310 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Choroidal hemangioma 10 year old black malevaatamisi: 3210 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 4170 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 2670 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 2570 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 2070 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Roth Spot and Endocarditisvaatamisi: 3670 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisaug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 26aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 36aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 35aug 13, 2025
|
|
Choroidal Nevus with Halovaatamisi: 30aug 13, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 27aug 13, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 55aug 13, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3123-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3423-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3323-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3623-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 2223-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3423-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 2223-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 2723-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3023-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3123-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3623-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 3023-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)vaatamisi: 2723-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 3248 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 4048 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2948 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2448 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2948 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 3748 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 3348 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 4848 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2748 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2948 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 2348 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Bear tracks (and diabetic retinopathy)vaatamisi: 3648 year old female with bear tracks in her retina and NPDR.juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3428 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 4028 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2828 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3428 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3628 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3228 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2428 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 4128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3128 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2728 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2028 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2528 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3328 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2928 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 2728 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 3428 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Small choroidal melanomavaatamisi: 4028 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 juuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 3567 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 3567 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 3467 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 3667 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 2967 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 3467 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 2467 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Acute retinal necrosisvaatamisi: 4267 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODjuuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 3348 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 3348 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 3348 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 3448 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 3348 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Ischemic Optic Neuropathy associated with GLP-1 Agonistvaatamisi: 2448 year old female woke up with blurry vision inferiorly in the right eye. the right optic nerve isnoted to be swollen. She does not have any pain with eye movements. The left eye is OK.
Medical History: Migraines
Surgical History: LASIK OU (2006)
Systemic Meds: Mounjaro (tirzepatide) injection qweekly since 8/2024, Prozac, Nexium, Sumatriptan.
VA OD: Dcc 20/20
VA OS: Dcc 20/16-1juuli 28, 2025
|
|
Astrocytoma (Astrocytic Hamartoma) no calcificationvaatamisi: 12038 year old man with no symptomsapr 14, 2025
|
|
Astrocytoma (Astrocytic Hamartoma) no calcificationvaatamisi: 12138 year old man with no symptomsapr 14, 2025
|
|
Astrocytoma (Astrocytic Hamartoma) no calcificationvaatamisi: 12938 year old man with no symptomsapr 14, 2025
|
|
Astrocytoma (Astrocytic Hamartoma) no calcificationvaatamisi: 9538 year old man with no symptomsapr 14, 2025
|
|
Astrocytoma (Astrocytic Hamartoma) no calcificationvaatamisi: 7838 year old man with no symptomsapr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 70apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 75apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 67apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 69apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 66apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 70apr 14, 2025
|
|
Macular fold - resolved with timevaatamisi: 75apr 14, 2025
|
|
|
|
